Crispr Therapeutics Ag (CRSP)

Operating Income

-$114.80M

Quarterly · Period ending: · USD

CRSP logo

CRSP Operating Income

Latest reported-$114.80M
CRSP Quarterly Operating Income (-$3.74M → -$114.80M)
High-resolution chart · PNG

CRSP operating income history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Operating Income — Quarterly (USD)
Period endingOperating Income (USD)
-114,796,000
-130,248,000
-154,764,000
-132,059,000
-133,071,000
-148,424,000
-64,588,000
-110,130,000
-151,260,000
-140,587,000
69,583,000
-132,411,000
-95,223,000
-64,487,000
-131,541,000
-182,388,000
-183,260,000
-175,972,000
-145,698,000
-128,849,000
762,618,000
-114,543,000
-107,761,000
-92,399,000
-80,689,000
-73,586,000
10,983,000
139,163,000
-54,983,000
-48,423,000
-45,228,000
-49,432,000
-37,286,000
-26,997,000
972,000
-23,570,000
-21,306,000
-20,744,000
-25,310,000
-14,610,000
-16,558,000
-11,652,000
-12,166,000
-6,202,000
-3,625,000
-3,736,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.